Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mittelman

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Blood|September 6, 2001
Myelodysplastic syndromes standardized response criteria: further definitionB D Cheson, J M Bennett, H Kantarjian, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 7, 2016
Miscommunicating NOTA Can Be Costly to Living DonorsM Mittelman, C Thiessen, W J Chon, et al.
Blood|November 23, 2000
Report of an international working group to standardize response criteria for myelodysplastic syndromesB D Cheson, J M Bennett, H Kantarjian, et al.
Journal of Internal Medicine|December 8, 2016
Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndromeH K G Garelius, W T Johnston, A G Smith, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Blood|September 6, 2001
Myelodysplastic syndromes standardized response criteria: further definitionB D Cheson, J M Bennett, H Kantarjian, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 7, 2016
Miscommunicating NOTA Can Be Costly to Living DonorsM Mittelman, C Thiessen, W J Chon, et al.
Blood|November 23, 2000
Report of an international working group to standardize response criteria for myelodysplastic syndromesB D Cheson, J M Bennett, H Kantarjian, et al.
Journal of Internal Medicine|December 8, 2016
Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndromeH K G Garelius, W T Johnston, A G Smith, et al.
Pageof 12